RecruitingDiabetic Peripheral Neuropathic Pain
Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy
Eligible age
18–80 yrs
Accepts
All genders
Locations
15 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this study is to evaluate the efficacy, safety, and tolerability of VX-993 in participants with pain associated with Diabetic Peripheral Neuropathy (DPN)
Sponsor: Vertex Pharmaceuticals Incorporated
Where it's recruiting
Alabama
Cullman
California
Bakersfield · La Mesa
Colorado
Wheat Ridge
Florida
DeLand · Fort Myers · Hallandale · Jupiter …
Georgia
Atlanta · Decatur
Idaho
Meridian
Illinois
Flossmoor
Michigan
Farmington Hills
Missouri
Hazelwood
North Carolina
Raleigh
Ohio
Beachwood
Rhode Island
East Greenwich
Source: ClinicalTrials.gov · NCT06619860 · last updated 2026-06-01